Navigation Links
Cantel Medical's Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
Date:10/13/2009

ol products." Mr. Krakauer continued, "We have invested significant dollars, resources and time towards this goal, and it has been a superb cross-divisional effort that demonstrates how we are gaining leverage from expertise in our various companies."

Within the United States, the sale of face masks treated with BIOSAFE antimicrobial for medical applications is subject to a 510(k) clearance by the U.S. Food and Drug Administration. At this time, the Company is awaiting publication of the latest revision of the FDA Guidance Document pertaining to antimicrobial treatments of medical devices prior to the filing of its 510(k) Premarket Notification submission. The Company is in the process of submitting an application to the U.S. Environmental Protection Agency covering the sale of treated masks in the United States for non-medical applications.

About BIOSAFE, Inc.

Pittsburgh-based BIOSAFE, Inc. manufactures and sells an antimicrobial polymer, HM 4100. HM4100 is effective in defending against bacteria, fungi (mold and mildew), yeast, algae and even certain viruses. BIOSAFE's patented technology is an excellent antimicrobial additive for treating plastics, textiles, metals, ceramics, and activated carbon, with superior performance and economic benefits. For further information, visit the BIOSAFE website at http://www.biosafe.com.

About Crosstex International, Inc.

A division of Cantel Medical Corp., Crosstex manufactures a wide array of infection prevention and control products for the healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex sells branded and private label products including face masks, which are 100% manufactured in its FDA-registered New York facility. Sold in more than 100 countries, Crosstex products include sterilization pouches and accessories, patient towels and bibs, eyewear, surface disinf
'/>"/>

SOURCE Cantel Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
2. Cantel Medical Corp. To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results
3. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
6. New Places and People - Truphatek opens USA subsidiary
7. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
8. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
9. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
Breaking Medicine Technology:Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... ALEXANDRIA, Va., April 16, 2012 Thirty years ... was passed, enabling tens of millions of Americans ... at life,s end from the nation,s dedicated hospice ... the most compassionate corps of trained volunteers seen ...
... PITTSBURGH, April 16, 2012  Mastech Holdings, Inc. (NYSE ... provider of Information Technology and Specialized Healthcare Staffing services, has scheduled ... first quarter ended March 31, 2012.  The conference ... at 9:00 a.m. Eastern Time and will be ...
Cached Medicine Technology:Thirty Years Since Medicare Hospice Legislation Recognized Value of Hospice Volunteers 2Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012 2
(Date:5/29/2015)... Dot Hill can mark one more item off her ... Prince Woods retirement community is the oldest woman to have ... “It was great fun!”, she exclaimed. “I’ve always wanted to ... so they thought this would be ok.” , “We put on ... tunnel,” she described. “I don’t remember it being noisy, but ...
(Date:5/29/2015)... Tennessee (PRWEB) May 29, 2015 Jan Wooden ... belief in one thing above all else: God does no ... the subject of her son’s passing is titled “God Does ... person is confronted with great personal tragedy. , “My ... losing someone dear to you into something productive, something healing,” ...
(Date:5/29/2015)... 2015 A group of doctors have discovered ... national effort to teach this “new math” to children in ... been “sickened” by the recent implementation of Common Core Math ... it, Common Core is now a reality in children’s classrooms ... are now seeking ways to improve common core math training ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... Chicago, Ill (PRWEB) May 29, 2015 ... Care , a dozen medical pioneers recognized by a ... changed the course of cancer treatment. Honorees will be ... of Cancer Care™ Award Ceremony, held 8:30-11:00 p.m. CDT ... , The 2015 honorees are being recognized for groundbreaking ...
Breaking Medicine News(10 mins):Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Turning grief from a child’s passing into virtue 2Health News:Doctors Discover a Cure for the Common Core 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4
... Health Market Science,(HMS) has been named to Deloitte,s ... ranking of the 50 fastest growing technology,media, telecommunications ... & Touche USA LLP, one of the nation,s ... percentage revenue growth,over five years from 2002-2006. The ...
... Jack Group, Inc.,(MattsonJack) announces the release of its ... help clients make strategic,decisions based on an in-depth ... conditions. Comorbidity Database(TM) consists of,two modules: Comorbidity Database(TM) ... and Comorbidity Database(TM) -- Med 2.0, which features ...
... the Board of Governors Gene Therapeutics Research Institute at ... that it is possible to sustain therapeutic gene expression ... year, even in the presence of an anti-viral immune ... , The researchers demonstrated in an animal model that ...
... Therapeutics Inc.,("Transition") (NASDAQ: TTHI , TSX: TTH) ... half of the US$15 million upfront payment,under the ... Corporation, plc ("Elan") (NYSE: ELN ) for ... completed Phase I clinical trials and the drug,candidate ...
... One of the nation,s largest and most respected radiology ... with AMICAS to revolutionize radiology IT solutions, ... AMCS ),a leader in radiology and medical image and ... new enterprise agreement,with Radiology Ltd. of Tucson, AZ. ...
... 26 People with,diabetes who have asymptomatic heart disease ... to their hearts without surgical intervention, according,to a study ... which,comes out on October 26, 2007., Researchers found ... aggressively treated their cardiac risk factors with,medication were able ...
Cached Medicine News:Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 2Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 3Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 3Health News:Aggressively Treating Cardiac Risk Factors May Reverse Ischemia 2
... third-generation immunoassay system combines continuous ... processing with a broad testing ... higher volume clinical laboratories to ... tests simultaneously, as well as ...
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
The ADx system uses fluorescence polarization immunoassay technology for the detection of abused drugs and toxicology assays....
... The Bayer Immuno 1 provides ... immunoassay instrument with over 50 ... endocrinology, tumor marker, therapeutic drug, ... can be performed on a ...
Medicine Products: